flow study glp 1 Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes Abstract 4365133: Impact of GLP-1

Regulatory agencies are fast-tracking reviews: in 2024, the FDA and EMA accelerated reviews of new obesity drugs, recognizing the public health crisis of obesity

Since GLP-1 also affects heart rate and inflammation, widespread activation could cause downstream effects such as autonomic dysfunction or muscle breakdown, disrupting a complex, age-old signaling network

JASPAR database analysis revealed a high-affinity PPARa binding motif within the FSP1 promoter

There is ample evidence that ES leads to long-lasting changes in synaptic plasticity influencing both the pre- and post-synapse [172, 173]

In the nucleus, FOXO4 activates the transcription of genes encoding antioxidant enzymes like manganese superoxide dismutase (MnSOD), catalase (CAT), and glutathione peroxidase (GPX)